EUVIMEDEUVIMED entdecken
Crossref

Therapeutic Use of Mesenchymal Stem Cells in Ophthalmology: A Review of Clinical Evidence

Jack M Gemayel, Frederic F Harb, Alain M Chebly, Georges G Azar, Charbel T Khalil

Journal of Ophthalmology and Advance Research · 13.03.2026 · 7 (1) · 1-17

DOI: 10.46889/joar.2026.7110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ophthalmology and Advance Research, online erschienen am 13.03.2026. Verfasst von Jack M Gemayel und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 1 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Degenerative ocular disorders, glaucoma, cataracts and age-related macular degeneration, are major contributors to global blindness and visual impairment. Other conditions, such as limbal stem cell deficiency, dry eye disease and retinitis pigmentosa, lead to significant ocular distress and progressive vision loss, profoundly affecting patients’ quality of life. Conventional therapies primarily focus on symptom management and slowing disease progression, offering limited potential for tissue restoration. In recent years, stem cell therapy and regenerative medicine have emerged as promising strategies to address these limitations. Mesenchymal Stem Cells (MSCs) induced Pluripotent Stem Cells (iPSCs) and other progenitor cells have demonstrated the capacity to differentiate into ocular-specific cell types, modulate inflammation, secrete neurotrophic factors and promote tissue repair. Preclinical studies and early clinical trials have shown encouraging results in corneal regeneration, retinal repair and optic nerve protection, highlighting the translational potential of these therapies. Despite these advances, challenges remain, including optimizing cell sourcing, delivery methods, immune compatibility and long-term safety. This review provides a comprehensive overview of current stem cell-based approaches in ophthalmology, discussing underlying mechanisms, preclinical and clinical evidence and future directions for regenerative interventions aimed at restoring visual function. Stem cell therapy offers a transformative approach with the potential to shift ophthalmic care from palliative management to true tissue regeneration, offering hope for patients with previously untreatable ocular disorders.

Zitieren

APA

Gemayel, J. M., Harb, F. F., Chebly, A. M., Azar, G. G., & Khalil, C. T. (2026). Therapeutic Use of Mesenchymal Stem Cells in Ophthalmology: A Review of Clinical Evidence. Journal of Ophthalmology and Advance Research, 7(1), 1-17. https://doi.org/10.46889/joar.2026.7110

Vancouver

Gemayel JM, Harb FF, Chebly AM, Azar GG, Khalil CT. Therapeutic Use of Mesenchymal Stem Cells in Ophthalmology: A Review of Clinical Evidence. Journal of Ophthalmology and Advance Research. 2026;7(1):1-17. doi:10.46889/joar.2026.7110

BibTeX
@article{Gemayel2026,
  author = {Gemayel, Jack M and Harb, Frederic F and Chebly, Alain M and Azar, Georges G and Khalil, Charbel T},
  title = {Therapeutic Use of Mesenchymal Stem Cells in Ophthalmology: A Review of Clinical Evidence},
  journal = {Journal of Ophthalmology and Advance Research},
  year = {2026},
  volume = {7},
  number = {1},
  pages = {1--17},
  doi = {10.46889/joar.2026.7110}
}
Kostenlos starten →